0001446472-22-000003.txt : 20221118
0001446472-22-000003.hdr.sgml : 20221118
20221118171158
ACCESSION NUMBER: 0001446472-22-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20221118
DATE AS OF CHANGE: 20221118
EFFECTIVENESS DATE: 20221118
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-PATH HOLDINGS INC
CENTRAL INDEX KEY: 0001133818
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 870652870
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-465381
FILM NUMBER: 221402775
BUSINESS ADDRESS:
STREET 1: 4710 BELLAIRE BOULEVARD
STREET 2: SUITE 210
CITY: BELLAIRE
STATE: TX
ZIP: 77401
BUSINESS PHONE: (832) 742-1357
MAIL ADDRESS:
STREET 1: 4710 BELLAIRE BOULEVARD
STREET 2: SUITE 210
CITY: BELLAIRE
STATE: TX
ZIP: 77401
FORMER COMPANY:
FORMER CONFORMED NAME: OGDEN GOLF CO CORP
DATE OF NAME CHANGE: 20010205
D
1
primary_doc.xml
X0708
D
LIVE
0001133818
BIO-PATH HOLDINGS INC
4710 BELLAIRE BOULEVARD
SUITE 210
BELLAIRE
TX
TEXAS
77401
(832) 742-1357
DELAWARE
OGDEN GOLF CO CORP
Corporation
true
Peter
H.
Nielsen
4710 Bellaire Boulevard
Suite 210
Bellaire
TX
TEXAS
77401
Executive Officer
Director
Heath
W.
Cleaver
4710 Bellaire Boulevard
Suite 210
Bellaire
TX
TEXAS
77401
Director
Paul
D.
Aubert
4710 Bellaire Boulevard
Suite 210
Bellaire
TX
TEXAS
77401
Director
Aline
Sherwood
4710 Bellaire Boulevard
Suite 210
Bellaire
TX
TEXAS
77401
Director
Douglas
P.
Morris
4710 Bellaire Boulevard
Suite 210
Bellaire
TX
TEXAS
77401
Director
Biotechnology
Decline to Disclose
- 06b
false
2022-11-09
false
true
true
false
0
ROTH Capital Partners, LLC
15407
None
None
888 SAN CLEMENTE
SUITE 400
NEWPORT BEACH
CA
CALIFORNIA
92660
All States
false
2280000
2280000
0
Includes warrants to purchase up to 800,000 shares of common stock issued to investors at an exercise price equal to $2.85 per share. As of the date hereof, no such warrants have been exercised.
false
5
140000
0
ROTH Capital Partners, LLC received the above sales commission in connection with a concurrent registered direct offering by the Issuer, which is not reported on this Form D.
0
true
false
BIO-PATH HOLDINGS INC
/s/ Peter H. Nielsen
Peter H. Nielsen
President and Chief Executive Officer
2022-11-18